NucMed was founded by managing director Harrie Buurlage in 2018.
NucMed is a new independent world-wide operating strategic consultancy firm. Our mission is to consistently improve access to nuclear medicine, for everyone. NucMed firmly believes that everyone should get the best health care available, including the unique value of nuclear medicine.
NucMed and her business partners will actively develop and improve nuclear medicine production supply chain processes so that nuclear medicines are more and more becoming available and affordable. NucMed sees herself as catalyst and enabler.
- Consultancy services for industry, research centers and governments
- Training programs
- Supply chain services, including development, production and management
Meet Harrie Buurlage
Harrie Buurlage has held many senior executive positions in (radio)pharmaceutical management for almost 25 years.
In his previous job as first COO and later CEO of NRG he championed a complex multi-year transition process. NRG is in the process of transitioning from a nuclear scientific semi-governmental organization towards a client-oriented pharmaceutical healthcare company.
In earlier executive jobs working for Mallinckrodt as senior director nuclear Harrie was globally responsible for many operational and commercial optimization processes.
Harrie holds a MSc degree in Applied Physics.